Tisch MS News

Tisch MS Patient Symposium 2014 Review

Thank you to all who attended the 17th Annual Tisch MS Research Patient Symposium. In response to your requests, a review of the material presented will be posted on this website and appear in the next issue of our newsletter, Healing MS.

October 21, 2014

More

Tisch MSRCNY Review Accepted for Publication in the "Journal of Molecular Diagnosis and Therapy"

Dr. Violaine Harris and Dr. Saud A. Sadiq co-authored a review entitled “Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status and this has been accepted for publication in the Journal Molecular Diagnosis and Therapy . " Biomarkers of Therapeutic Response in Multiple Sclerosis:...

October 1, 2014

More

The journal "Neurology® Neuroimmunology and Neuroinflammation," accepted a paper by Dr. Fozia Mir for Publication

The journal Neurology® Neuroimmunology and Neuroinflammation accepted a paper by lead author Dr. Fozia Mir entitled, “Cerebrospinal fluid isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.” The paper is authored by Dr. Mir, Donald Lee, Hetal Ray, and Saud A. Sadiq, MD and...

September 25, 2014

More

Tisch MSRCNY Presentations well received at the ACTRIMS-ECTRIMS Meeting

Last week your Tisch MSRCNY researchers presented six abstracts, including five posters, at the Joint ACTRIMS-ECTRIMS Meeting (Americas and European Committees for Treatment and Research in Multiple Sclerosis) in Boston. This was the sixth triennial event dedicated to advancing the understanding of...

September 17, 2014

More

Tisch MS Research Center in September Issue of "Neurology Today"

Tisch MS Research Center of New York is proud to be featured in the September 2014 issue of “Neurology Today.” The article “Myelinating Oligodendrocytes Derived from Primary Progressive MS Patients: Scientists Developed Faster, More Efficient Methodology,” discusses research focusing on an...

September 12, 2014

More

Tisch MS Researchers to Present at 2014 Joint ACTRIMS-ECTRIMS Meeting

Your Tisch MS Researchers head to Boston today to present their work at the 2014 Joint ACTRIMS-ECTRIMS Meeting! We will bring you updates from this important conference discussing the latest research and treatments in MS. http://www.msboston2014.org/

September 10, 2014

More

Dr. Massimiliano Cristofanilli and Team Succeed in Three-year Effort to Create Model of Progressive Multiple Sclerosis

The Tisch Center is excited to announce that a team led by Dr. Massimiliano Cristofanilli has succeeded in a three year effort to create a model of progressive multiple sclerosis. Currently the widely used experimental model of multiple sclerosis known as EAE best mimics relapsing-remitting MS (...

August 8, 2014

More

ISSCR - International Society for Stem Cell Research, 12th Annual Meeting in Vancouver, Canada, June 18-21, 2014

The Tisch MS Research Center presented two posters at the International Society for Stem Cell Research (ISSCR) 12th Annual Meeting last week based on the following study. Safety and Dosing of Autologous Neural Progenitors Injected Intrathecally in Multiple Sclerosis Patients: Results of a Pilot...

June 25, 2014

More

Dr. Saud A. Sadiq Elected AAN Fellow Member

We are pleased to announce, Dr. Saud A. Sadiq, Director of the International Multiple Sclerosis Management Practice (IMSMP) and Tisch MS Research Center of New York (Tisch MSRCNY) has been elected a Fellow Member of the American Academy of Neurology (AAN). This outstanding achievement recognizes...

June 23, 2014

More

International Society for Stem Cell Research 12th Annual Meeting

Your Tisch MS researchers, Dr. Saud A. Sadiq and Dr. Violaine Harris, are presenting this week at the International Society for Stem Cell Research (ISSCR) 12th Annual Meeting. Updates to follow next week. For more info on the ISSCR and this important event, visit: www.isscr.org

June 20, 2014

More

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.